Benchmark Reiterates Buy on IMAX Corp. (IMAX) Ahead of 2Q Report
Tweet Send to a Friend
Benchmark reiterated a Buy rating on IMAX Corporation (NYSE: IMAX), and cut the price target by $0.01 to $43.57 ahead ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
